Effect of Dopamine D
Animals
Cerebellum
/ drug effects
Corpus Striatum
/ drug effects
Dopamine D2 Receptor Antagonists
/ pharmacology
Fluorine Radioisotopes
/ administration & dosage
Haloperidol
/ pharmacology
Kinetics
Male
Parkinson Disease
/ diagnostic imaging
Piperidines
/ administration & dosage
Positron-Emission Tomography
/ methods
Protein Binding
/ drug effects
Raclopride
/ pharmacology
Radiopharmaceuticals
/ administration & dosage
Rats
Rats, Wistar
Receptors, sigma
/ antagonists & inhibitors
Vesicular Acetylcholine Transport Proteins
/ metabolism
D2 receptor
Parkinson’s disease
animal studies
kinetic modeling
positron emission tomography
vesicular acetylcholine transporter
σ receptor
Journal
Molecular pharmaceutics
ISSN: 1543-8392
Titre abrégé: Mol Pharm
Pays: United States
ID NLM: 101197791
Informations de publication
Date de publication:
02 03 2020
02 03 2020
Historique:
pubmed:
6
2
2020
medline:
27
5
2021
entrez:
4
2
2020
Statut:
ppublish
Résumé
The interaction of dopaminergic and cholinergic neurotransmission in, e.g., Parkinson's disease has been well established. Here, D
Identifiants
pubmed: 32011892
doi: 10.1021/acs.molpharmaceut.9b01129
pmc: PMC7054895
doi:
Substances chimiques
Dopamine D2 Receptor Antagonists
0
Fluorine Radioisotopes
0
Piperidines
0
Radiopharmaceuticals
0
Receptors, sigma
0
Vesicular Acetylcholine Transport Proteins
0
fluoroethoxy-benzovesamicol
0
Raclopride
430K3SOZ7G
Haloperidol
J6292F8L3D
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
865-872Références
Neuroscience. 1997 Jan;76(2):467-77
pubmed: 9015331
Mol Imaging Biol. 2016 Aug;18(4):588-97
pubmed: 26637208
J Neurochem. 1986 Apr;46(4):1214-8
pubmed: 3950625
Eur J Med Chem. 2015 Jul 15;100:50-67
pubmed: 26071858
Bioorg Med Chem. 2010 Nov 1;18(21):7659-67
pubmed: 20889347
J Recept Signal Transduct Res. 2016 Aug;36(4):327-388
pubmed: 26056947
J Chem Neuroanat. 1997 Jun;13(1):23-39
pubmed: 9271193
Acta Anaesthesiol Scand. 1997 Nov;41(10):1335-40
pubmed: 9422302
J Pharmacol Exp Ther. 1996 May;277(2):775-83
pubmed: 8627558
J Cereb Blood Flow Metab. 1983 Mar;3(1):1-7
pubmed: 6822610
PLoS One. 2015 Mar 30;10(3):e0122363
pubmed: 25823005
Synapse. 1992 Sep;12(1):47-54
pubmed: 1411963
Synapse. 1998 Nov;30(3):263-74
pubmed: 9776130
Brain Res Bull. 1997;43(1):107-15
pubmed: 9205804
Int J Nurs Stud. 2012 Aug;49(8):1039-47
pubmed: 22377339
ACS Chem Neurosci. 2017 Mar 15;8(3):444-453
pubmed: 28170220
J Neurochem. 2010 Nov;115(4):984-93
pubmed: 20831599
J Pharmacol Exp Ther. 1976 Feb;196(2):323-32
pubmed: 943521
Br J Anaesth. 2013 Apr;110(4):592-9
pubmed: 23213036
Ann Neurol. 2006 Apr;59(4):591-6
pubmed: 16566021
Ann Neurol. 2019 Apr;85(4):538-549
pubmed: 30720884
Eur J Pharmacol. 1996 Dec 19;317(2-3):257-62
pubmed: 8997608
Nucl Med Biol. 2016 Feb;43(2):131-9
pubmed: 26872437
Nat Rev Neurosci. 2017 Jul;18(7):435-450
pubmed: 28592904
Neurobiol Aging. 2003 Mar-Apr;24(2):197-211
pubmed: 12498954
Biochemistry. 2004 Sep 7;43(35):11163-74
pubmed: 15366926
Curr Neurol Neurosci Rep. 2013 Sep;13(9):377
pubmed: 23943367
Synapse. 1994 Jul;17(3):182-9
pubmed: 7974201
Sleep Med. 2019 Jun;58:35-41
pubmed: 31078078
Lancet. 2015 Aug 29;386(9996):896-912
pubmed: 25904081
Contrast Media Mol Imaging. 2018 Jun 13;2018:4535476
pubmed: 30008624
CNS Neurosci Ther. 2008 Fall;14(3):248-62
pubmed: 18801115
J Nucl Med. 2003 May;44(5):815-22
pubmed: 12732684
Neuroreport. 1993 Sep 30;4(12):1311-4
pubmed: 8260611
Biochem Pharmacol. 1985 Jul 1;34(13):2251-9
pubmed: 4015674
Life Sci. 1996;58(16):1367-74
pubmed: 8614294
J Nucl Med. 1996 Jul;37(7):1192-7
pubmed: 8965197
J Comp Neurol. 1997 Feb 24;378(4):454-67
pubmed: 9034903